AiXin Life International (AIXN) 10-K 26 Jun 18 2017 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2017	May 15, 2018	Jun. 30, 2017
Document And Entity Information
Entity Registrant Name	AiXin Life International, Inc.
Entity Central Index Key	835,662
Document Type	10-K
Document Period End Date	Dec. 31, 2017
Amendment Flag	false
Entity a Well-known Seasoned Issuer	No
Entity a Voluntary Filer	No
Entity's Reporting Status Current	Yes
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Public Float			$ 0
Entity Common Stock, Shares Outstanding		317,988,089
Trading Symbol	AIXN
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2,017

Balance Sheets

Balance Sheets - USD ($)	Dec. 31, 2017	Dec. 31, 2016
CURRENT ASSETS
Cash & equivalents	$ 37,630	$ 29,668
Accounts receivable, net	32,362	175,259
Other receivables and prepaid expenses	22,023	3,782
Advances to suppliers	2,435	105,455
Deferred commission	422,594	335,110
Deferred travel cost	277,261	176,187
Inventory	48,902	46,570
Total current assets	843,207	872,031
NONCURRENT ASSETS
Property and equipment, net	1,719,012	2,816,934
Total non-current assets	1,719,012	2,816,934
TOTAL ASSETS	2,562,219	3,688,965
CURRENT LIABILITIES
Accounts payable	58,028	35,191
Unearned revenue	2,691,428	2,066,550
Taxes payable	1,290,550	1,193,050
Accrued liabilities and other payables	603,947	314,475
Advance from shareholder	988,380	2,095,064
TOTAL LIABILITIES	5,632,333	5,704,330
STOCKHOLDERS' DEFICIT
Undesignated preferred stock, $0.001 par value, 20,000,000 shares authorized, none issued and outstanding
Common stock, par value $0.00001 per share, 950,000,000 shares authorized; 317,988,089 and 272,764,004 shares issued and outstanding as of December 31, 2017 and 2016, respectively	3,180	2,728
Paid in capital	3,371,857	13,674
Statutory reserve	11,721	11,721
Accumulated deficit	(6,386,718)	(2,131,504)
Accumulated other comprehensive income (loss)	(70,154)	88,016
TOTAL STOCKHOLDERS' DEFICIT	(3,070,114)	(2,015,365)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 2,562,219	$ 3,688,965

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2017	Dec. 31, 2016
Statement of Financial Position [Abstract]
Undesignated preferred stock, par value	$ 0.001	$ 0.001
Undesignated preferred stock, shares authorized	20,000,000	20,000,000
Undesignated preferred stock, shares issued
Undesignated preferred stock, shares outstanding
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	950,000,000	950,000,000
Common stock, shares issued	317,988,089	272,764,004
Common stock, shares outstanding	317,988,089	272,764,004

Statements of Operations and Co

Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Income Statement [Abstract]
Net sales	$ 688,095	$ 3,082,725
Cost of Revenue	258,036	1,352,742
Gross profit	430,059	1,729,983
Operating expenses
Selling expenses	698,331	1,152,555
General and administrative expenses	4,820,652	2,640,324
Provision for bad debts	13,885	7,018
Asset impairment loss	14,468
Total operating expenses	5,547,336	3,799,897
Loss from operations	(5,117,277)	(2,069,914)
Non-operating income (expenses)
Financial expense	(761)	(669)
Gain from disposal of fixed assets	863,369
Other income	35,871	51,445
Other expense	(36,416)	(61,074)
Total non-operating income (expenses), net	862,063	(10,298)
Loss before income tax	(4,255,214)	(2,080,212)
Income tax expense
Net loss	(4,255,214)	(2,080,212)
Other comprehensive items
Foreign currency translation gain (loss)	(158,170)	89,979
Comprehensive loss	$ (4,413,384)	$ (1,990,233)
Loss per share - Basic and diluted	$ (0.015)	$ (0.008)
Weighted average shares outstanding	275,242,036	272,764,004

Statements of Cash Flows

Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (4,255,214)	$ (2,080,212)
Depreciation	196,658	211,114
Provision for bad debts	13,885	7,018
Impairment of inventory	14,468
Stock based compensation	3,617,927
Capital gain from disposal of fixed assets	(863,369)
Increase (decrease) in assets
Accounts receivable	134,848	(135,369)
Other receivables and prepaid expenses	(17,322)	(3,010)
Advances to suppliers	105,898	156,923
Deferred commission	(62,890)	(131,129)
Deferred travel cost	(86,092)	(28,044)
Inventory	(13,748)	148,020
Increase (decrease) in liabilities:
Accounts payable	19,744	24,789
Unearned revenue	470,031	(47,785)
Taxes payable	17,909	655,962
Accrued liabilities and other payables	248,053	249,826
Net cash (used in) operating activities	(459,214)	(971,897)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment	(7,773)	(272,468)
Net cash used in investing activities	(7,773)	(272,468)
CASH FLOWS FROM FINANCING ACTIVITIES:
Advance from shareholder	473,100	1,231,926
Net cash provided by financing activities	473,100	1,231,926
EFFECT OF EXCHANGE RATE CHANGE ON CASH & EQUIVALENTS	1,849	(2,312)
NET INCREASE (DECREASE) IN CASH & EQUIVALENTS	7,962	(14,751)
CASH & EQUIVALENTS, BEGINNING OF YEAR	29,668	44,419
CASH & EQUIVALENTS, END OF YEAR	37,630	29,668
Supplemental Cash flow data:
Income tax paid
Interest paid
Non-cash investing and financing activities:
Proceeds from disposal of fixed assets as repayment for advance from shareholder	$ 1,910,867

Statement of Stockholders' Defi

Statement of Stockholders' Deficit - USD ($)	Common Stock [Member]	Paid-in Capital [Member]	Statutory Reserve [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Total
Balance at Dec. 31, 2015	$ 2,728	$ 13,674	$ 11,721	$ (51,292)	$ (1,963)	$ (25,132)
Balance, shares at Dec. 31, 2015	272,764,004
Net loss				(2,080,212)		(2,080,212)
Foreign currency translation gain					89,979	89,979
Balance at Dec. 31, 2016	$ 2,728	13,674	11,721	(2,131,504)	88,016	(2,015,365)
Balance, shares at Dec. 31, 2016	272,764,004
Net loss				(4,255,214)		(4,255,214)
Foreign currency translation gain					(158,170)	(158,170)
Recapitalization upon reverse merger		(259,292)				(259,292)
Stocks to be issued for services	$ 452	3,617,475				$ 3,617,927
Stocks to be issued for services, shares	45,224,085					45,224,085
Balance at Dec. 31, 2017	$ 3,180	$ 3,371,857	$ 11,721	$ (6,386,718)	$ (70,154)	$ (3,070,114)
Balance, shares at Dec. 31, 2017	317,988,089

Organization and Description of

Organization and Description of Business	12 Months Ended
	Dec. 31, 2017
Accounting Policies [Abstract]
Organization and Description of Business	1. ORGANIZATION AND DESCRIPTION OF BUSINESS Aixin Life International, Inc. (the “Company” or “Aixin” During 2001, Mercari was reactivated. From November 30, 2001 to March 1, 2004, Mercari was in the development stage. On November 9, 2009, Mercari entered into a Stock Purchase Agreement (the “Stock Purchase Agreement”) with Algodon Wines & Luxury Development Group, Inc. or “Algodon” (formerly Diversified Private Equity Corporation or “DPEC”), a then privately-held Delaware corporation, and Kanouff, LLC (“KLLC”) and Underwood Family Partners, Ltd. (the “Partnership”), of which KLLC and the Partnership were the majority shareholders of the Company (the “Stock Purchase”). In connection with the Stock Purchase, Algodon purchased and the Company sold, 43,822,001 shares of common stock for $43,822, or $0.001 per share. In addition, Algodon purchased 200 shares of common stock from KLLC and 200 shares of common stock from the Partnership for a purchase price of $180,000 payable to each selling shareholder. Immediately following the closing of the transactions contemplated by the Stock Purchase Agreement, Algodon owned an aggregate of 43,822,401 shares of the Company’s common stock, or approximately 96.5% of our outstanding shares. During each of the years since Mercari was reactivated, the Company had no revenue and had losses approximately equal to the expenditures required to reactivate and comply with filing and reporting obligations. Expenditures were paid by Mercari from capital contributions and loans made by Mercari’s principal stockholders and entities controlled by Mercari’s directors. On January 20, 2017, Algodon sold all of the 43,822,401 shares of the Company’s common stock which it owned, approximately 96.5% of the Company’s outstanding shares, to China Concentric, for $260,000, and assigned its right to the repayment of $150,087 of non-interest bearing advances to the Company for working capital made over some period of time as the Company’s controlling stockholder, pursuant to a Stock Purchase Agreement dated December 20, 2016, as amended. Prior to entering into the Stock Purchase Agreement with Algodon, neither China Concentric nor any of its affiliates had any relationship to the Company, Algodon or any of their respective affiliates. On February 2, 2017, Mr. Quanzhong Lin purchased 29,521,410 shares of the Company’s common stock, approximately 65% of its outstanding shares of common stock, from China Concentric for $300,000, pursuant to a Stock Purchase Agreement dated December 21, 2016, which resulted in a change in control of our company. The 29,521,410 shares are still being transferred from China Concentric to Mr. Lin. On December 12, 2017, the Company issued 227,352,604 shares of common stock to Mr. Lin, the sole stockholder of AiXin (BVI) International Group Co., Ltd. a British Virgin Islands corporation (“AiXin BVI”), for his shares of AiXin BVI, pursuant to a Share Exchange Agreement. Mr. Lin now owns 256,874,014 shares of the Company’s common stock, approximately 80.8% of its outstanding shares. As a result of the Share Exchange, AiXin BVI became the Company’s wholly-owned subsidiary, and the Company now owns all of the outstanding shares of HK AiXin International Group Co., Limited, a Hong Kong limited company (“AiXin HK”), which in turn owns all of the outstanding shares of Chengdu AiXin Zhonghong Biological Technology Co., Ltd., a Chinese limited company (“AiXin Zhonghong”), which markets and sells premium-quality nutritional products in China. AiXin BVI was incorporated on September 21, 2017 to serve as a holding company and AiXin HK was established in Hong Kong on February 25, 2016 to serve as an intermediate holding company. AiXin Zhonghong was established in the PRC on March 4, 2013, and on May 27, 2017, the local government of the PRC issued a certificate of approval regarding the foreign ownership of AiXin Zhonghong by AiXin HK. Neither AiXin BVI nor AiXin HK had operations prior to December 12, 2017. For accounting purposes, the acquisition was accounted for as a reverse acquisition and was treated as a recapitalization of Mercari effected by a share exchange, with AiXin BVI as the accounting acquirer. Since neither AiXin BVI nor AiXin HK had operations prior to December 12, 2017, the historical financial statements of AiXin Zhonghong are now the historical financial statements of the Company. The assets and liabilities of AiXin Zhonghong have been brought forward at their book value and no goodwill has been recognized. Effective February 1, 2018, pursuant to Articles of Amendment to the Company’s Articles of Incorporation filed with the Secretary of State of Colorado, the Company changed its name to AiXin Life International., Inc. The Company, through its indirectly owned AiXin Zhonghong subsidiary, mainly develops and distributes innovative consumer products by offering a comprehensive line of premium-quality nutritional products. The Company sells the products through exhibition events, conferences, as well as person-to-person marketing. During 2017, the Company’s revenue was primarily generated from sales of 20 products, which include Oleesa Milk Powder, CO Q10, D-Ribose Powder, and other nutritional supplements. The Company’s business mainly focuses on a proactive approach to its customers such as hosting events for clients, which it believes is ideally suited to marketing its products because sales of nutrition products are strengthened by ongoing personal contact and support, coaching and education of its clients, as to the benefits of a healthy and active lifestyle.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2017
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying financial statements are prepared in conformity with U.S. Generally Accepted Accounting Principles (“US GAAP”). The functional currency of Aixin is Chinese Renminbi (‘‘RMB’’). The accompanying financial statements are translated from RMB and presented in U.S. dollars (“USD”). Going Concern The Company incurred net losses of $4.3 million and $2.1 million for the years ended December 31, 2017 and 2016 respectively. The Company also had a shareholders’ deficit of $3.1 million as of December 31, 2017. These conditions raise a substantial doubt about the Company’s ability to continue as a going concern. The Company plans to increase its income by improving communications with suppliers to ensure sufficient and quality products supply, building a competitive and efficient sales force, providing attractive sales incentive program, increasing marketing and promotion activities, and minimize operating costs. The Company’s majority shareholder, Quanzhong Lin, plans to invest additional RMB 10 million into the Company by the end of July 2018 to help the Company’s working capital needs. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Use of Estimates In preparing financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Significant estimates, required by management, include the recoverability of long-lived assets, allowance for doubtful accounts, and the reserve for obsolete and slow-moving inventories. Actual results could differ from those estimates. Cash and Equivalents For financial statement purposes, the Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Accounts Receivable The Company’s policy is to maintain an allowance for potential credit losses on accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. During the years ended December 31, 2017 and 2016, bad debt expense was $13,885 and $7,018, respectively. As of December 31, 2017 and December 31, 2016, the bad debt allowance was $24,524 and $9,475, respectively. Inventory Inventory mainly consists of health supplement products. Inventory is valued at the lower of average cost or market, cost being determined on a moving weighted average method at the end of the month. Management compares the cost of inventories with the net realizable value and an allowance is made for writing down their inventories to market value, if lower. The Company recorded inventory impairment of $14,468 and $0 at December 31, 2017 and 2016, respectively. In July 2015, the FASB issued Accounting Standards Update (“ASU”) 2015-11, “Inventory (Topic 330) - Simplifying the Measurement of Inventory,” which requires that inventory within the scope of the guidance be measured at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Property and Equipment Property and equipment are stated at cost, less accumulated depreciation, and impairment losses, if any. Major repairs and betterments that significantly extend original useful lives or improve productivity are capitalized and depreciated over the period benefited. Maintenance and repairs are expensed as incurred. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Building 20 years Office furniture 5 years Electronic Equipment 3 years Vehicles 5 years Impairment of Long-Lived Assets Long-lived assets, which include property and equipment and intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable, but at least annually. Recoverability of long-lived assets to be held and used is measured by comparing of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by it. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds its fair value (“FV”). FV is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. Based on its review, the Company believes that, as of December 31, 2017 and December 31, 2016, there was no significant impairments of its long-lived assets. Income Taxes Income taxes are accounted for using an asset and liability method. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each period end based on enacted tax laws and statutory tax rates, applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. The Company follows Accounting Standards Codification (“ASC”) Topic 740, which prescribes a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740 also provides guidance on recognition of income tax assets and liabilities, classification of current and deferred income tax assets and liabilities, accounting for interest and penalties associated with tax positions, accounting for income taxes in interim periods, and income tax disclosures. Under ASC Topic 740, when tax returns are filed, it is likely that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. The benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50% likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination. Interest associated with unrecognized tax benefits is classified as interest expense and penalties are classified in selling, general and administrative expenses in the statement of income. At December 31, 2017 and 2016, the Company did not take any uncertain positions that would necessitate recording a tax related liability. Revenue Recognition The Company’s revenue recognition policies comply with FASB ASC Topic 605, “Revenue Recognition”. Sales are recognized when a formal arrangement exists; the price is fixed or determinable; title has passed to the buyer, which generally is at the time of delivery of the products or services; no other significant obligations of the Company exist and collectability is reasonably assured. Payments received before all of the relevant criteria for revenue recognition are recorded as unearned revenue. Sales revenue represents the invoiced value of goods, net of value-added taxes (“VAT”). All of the Company’s products sold in China are subject to the PRC VAT of 17% of the gross sales price. This VAT may be offset by VAT paid by the Company on raw materials and other materials purchased in China. The Company records VAT payable and VAT receivable net of payments in the financial statements. The VAT tax return is filed offsetting the payables against the receivables. Sales and purchases are recorded net of VAT collected and paid as the Company acts as an agent for the government. The Company’s sales policy allows for the return of unopened products for cash after deducting certain service and transaction fees. As alternatives for the product return option, the customers have options of asking an exchange of the products with same value. The amount for return of products was immaterial for the years ended December 31, 2017 and 2016. Cost of Revenue Cost of revenue (“COR”) consists primarily of cost of purchasing inventory. Write-down of inventory to lower of cost or market is also recorded in COR. Concentration of Credit Risk The operations of the Company are in the PRC. Accordingly, the Company’s business, financial condition, and results of operations may be influenced by the political, economic, and legal environments in the PRC, and by the general state of the PRC economy. The Company has cash on hand and demand deposits in accounts maintained with state-owned banks within the PRC. Cash in state-owned banks is covered by insurance up to RMB 500,000 ($72,500) per bank. The Company has not experienced any losses in such accounts and believes they are not exposed to any risks on their cash in these bank accounts. Statement of Cash Flows In accordance with ASC Topic 230, “Statement of Cash Flows,” Fair Value (“FV”) of Financial Instruments Certain of the Company’s financial instruments, including cash and equivalents, accrued liabilities and accounts payable, carrying amounts approximate their FV due to their short maturities. FASB ASC Topic 825, “Financial Instruments,” requires disclosure of the FV of financial instruments held by the Company. The carrying amounts reported in the balance sheets for current liabilities each qualify as financial instruments and are a reasonable estimate of their FV because of the short period of time between the origination of such instruments and their expected realization and the current market rate of interest. Fair Value Measurements and Disclosures ASC Topic 820, “Fair Value Measurements and Disclosures,” defines FV, and establishes a three-level valuation hierarchy for disclosures of FV measurement that enhances disclosure requirements for FV measures. The three levels are defined as follow: ● Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets. ● Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. ● Level 3 inputs to the valuation methodology are unobservable and significant to the FV measurement. As of December 31, 2017 and 2016, the Company did not identify any assets and liabilities that are required to be presented on the balance sheet at FV. Foreign Currency Translation and Comprehensive Income (Loss) The functional currency of the Company is RMB. For financial reporting purposes, RMB is translated into USD as the reporting currency. Assets and liabilities are translated at the exchange rate in effect at the balance sheet dates. Revenues and expenses are translated at the average rate of exchange prevailing during the reporting period. Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders’ equity as “Accumulated other comprehensive income”. Gains and losses resulting from foreign currency transactions are included in income. There was no significant fluctuation in the exchange rate for the conversion of RMB to USD after the balance sheet date. The Company uses FASB ASC Topic 220, “Comprehensive Income”. Comprehensive income (loss) is comprised of net income (loss) and all changes to the statements of stockholders’ equity, except those due to investments by stockholders, changes in paid-in capital and distributions to stockholders. Comprehensive loss for 2017 and 2016 consisted of net loss and foreign currency translation adjustments. Earnings per Share Basic loss per share is computed on the basis of the weighted average number of common stock outstanding during the period. Diluted loss per share is computed on the basis of the weighted average number of common stock and common stock equivalents outstanding. Dilutive securities having an anti-dilutive effect on diluted loss per share are excluded from the calculation. Dilution is computed by applying the treasury stock method for options and warrants. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period. As of December 31, 2017 and 2016 and for the years then ended, the Company did not have any potentially dilutive instruments. Stock-Based Compensation The Company periodically grants stock options and warrants to employees and non-employees in non-capital raising transactions as compensation for services rendered. The Company accounts for stock option and stock warrant grants to employees based on the authoritative guidance provided by the FASB where the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and stock warrant grants to non-employees in accordance with the authoritative guidance of the FASB where the value of the stock compensation is determined based upon the measurement date at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option or warrant grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date. For the year ended December 31, 2017, the Company’s board of directors (“BOD”) authorized the issuance of 45,224,085 shares of common stock to three individuals for services rendered to the Company. The stock-based compensation was valued at $3,617,927 based on the Company’s stock price at the date of agreement and was vested immediately for services already rendered. On January 15, 2018, the Company’s BOD determined that it is not in the Company’s best interests to issue any shares to two of the three individuals because BOD believes the two individuals did not perform the services as expected Segment Reporting ASC Topic 280, “Segment Reporting,” requires use of the “management approach” model for segment reporting. The management approach model is based on the way a company’s chief operating decision maker organizes segments within the Company for making operating decisions assessing performance and allocating resources. Reportable segments are based on products and services, geography, legal structure, management structure, or any other manner in which management disaggregates a company. Management determined that the Company’s operations constitute a single reportable segment in accordance with ASC 280. The Company operates exclusively in one business and industry segment: sale of health supplement products. New Accounting Pronouncements In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers, which supersedes the revenue recognition requirements in Accounting Standards Codification 605 - Revenue Recognition and most industry-specific guidance throughout the Codification. The standard requires that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. In August 2015, the FASB approved a one-year deferral of the effective date of the new revenue recognition standard. Public business entities, certain not-for-profit entities, and certain employee benefit plans should apply the guidance in ASU 2014-09 to annual reporting periods beginning after December 15, 2017, including interim reporting periods within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 31, 2016, including interim reporting periods within that reporting period. In March 2016, the FASB issued ASU 2016-08, Revenue from Contracts with Customers (Topic 606), Principal versus Agent Considerations (Reporting Revenue versus Net). In April 2016, the FASB issued ASU 2016-10, Revenue from Contracts with Customers (Topic 606), Identifying Performance Obligations and Licensing. In May 2016, the FASB issued ASU 2016-11, Revenue from Contracts with Customers (Topic 606) and Derivatives and Hedging (Topic 815) - Rescission of SEC Guidance Because of ASU 2014-09 and 2014-16, and ASU 2016-12, Revenue from Contracts with Customers (Topic 606) - Narrow Scope Improvements and Practical Expedients. These ASUs clarify the implementation guidance on a few narrow areas and adds some practical expedients to the guidance Topic 606. The Company is evaluating the effect that these ASUs will have on its financial statements and related disclosures. In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326), which requires entities to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. This replaces the existing incurred loss model and is applicable to the measurement of credit losses on financial assets measured at amortized cost. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early application is permitted for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. The Company is currently evaluating the impact that the standard will have on its financial statements and related disclosures. In August 2016, the FASB issued ASU No. 2016-15, Classification of Certain Cash Receipts and Cash Payments. ASU 2016-15 clarifies the presentation and classification of certain cash receipts and cash payments in the statement of cash flows. This ASU is effective for public business entities for fiscal years, and interim periods within those years, beginning after December 15, 2017. Early adoption is permitted. The Company is currently assessing the potential impact of ASU 2016-15 on its financial statements and related disclosures. In November 2016, the FASB issued ASU No. 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash. The guidance requires that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. The standard is effective for fiscal years beginning after December 15, 2017, and interim period within those fiscal years. Early adoption is permitted, including adoption in an interim period. The standard should be applied using a retrospective transition method to each period presented. The Company does not anticipate the adoption of this ASU will have a significant impact on its financial statements.

Deferred Commission

Deferred Commission	12 Months Ended
	Dec. 31, 2017
Deferred Commission
Deferred Commission	3. DEFERRED COMMISSION The Company paid commission to its salesmen based on cash collected from the sales. The Company calculated and paid commission based on certain proportion of monthly cash receipts from sales; however, the customers sometimes delays taking delivery of the products after payment is made to the Company, which is recorded as unearned revenue. Accordingly, the Company only recognizes current commission cost as the related revenue is recognized. Commission expenses are recorded as selling expenses. As of December 31, 2017 and 2016, the Company had deferred commission of $422,594 and $335,110 respectively.

Deferred Travel Cost

Deferred Travel Cost	12 Months Ended
	Dec. 31, 2017
Deferred Travel Cost
Deferred Travel Cost	4. DEFERRED TRAVEL COST As part of the Company’s sales incentive program, the Company occasionally provided free travel to its customers whose prepayment to purchase the Company’s products reached to certain amount. There are different travel incentive offering to its customers based on amount received from each customer. The Company recorded the to-be-provided free travel cost when cash is collected from customers as deferred travel cost with corresponding account of accrued travel cost, and recorded as net of sales once the prepayment from customers was recognized as revenue. As of December 31, 2017 and 2016, the Company had deferred travel cost of $277,261 and $176,187, respectively.

Inventory

Inventory	12 Months Ended
	Dec. 31, 2017
Inventory Disclosure [Abstract]
Inventory	5. INVENTORY Inventory consisted of the following at December 31, 2017 and 2016: 2017 2016 Finished goods – health supplements $ 63,930 $ 46,570 Less: Inventory impairment allowance (15,028 ) - Total $ 48,902 $ 46,570

Property and Equipment, Net

Property and Equipment, Net	12 Months Ended
	Dec. 31, 2017
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	6. PROPERTY AND EQUIPMENT, NET Property and equipment consisted of the following at December 31, 2017 and 2016: 2017 2016 Office furniture $ 242,613 $ 226,385 Building 1,600,118 2,641,211 Vehicle 225,636 211,639 Electronic equipment 14,041 6,776 Total 2,082,408 3,086,012 Less: Accumulated depreciation (363,396 ) (269,078 ) Net $ 1,719,012 $ 2,816,934 Depreciation for the years ended December 31, 2017 and 2016 was $196,658 and $211,114, respectively. During the year ended December 31, 2017, the Company sold a building for RMB 13,060,000 ($1,932,410). The net proceeds after commissions and taxes of RMB 12,914,407 ($1,910,867) were paid to the majority shareholder as repayment for advance from shareholder.

Taxes Payable

Taxes Payable	12 Months Ended
	Dec. 31, 2017
Income Tax Disclosure [Abstract]
Taxes Payable	7. TAXES PAYABLES Taxes payable consisted of the following at December 31, 2017 and 2016: 2017 2016 Income $ 37,629 $ 35,295 Value-added 1,149,055 1,075,161 City construction 50,218 47,137 Education 35,882 33,680 Other 17,766 1,777 Taxes payable $ 1,290,550 $ 1,193,050

Accrued Liabilities and Other P

Accrued Liabilities and Other Payables	12 Months Ended
	Dec. 31, 2017
Payables and Accruals [Abstract]
Accrued Liabilities and Other Payables	8. ACCRUED LIABILITIES AND OTHER PAYABLES Accrued liabilities and other payables consisted of the following at December 31, 2017 and 2016: 2017 2016 Accrued liability – travel cost (see Note 4) $ 88,864 $ 114,726 Salary payable 97,393 53,714 Other payables 417,690 146,035 Total $ 603,947 $ 314,475 Other payables mainly consisted of payables for employees’ social insurance and disabled employment security fund of $242,075 and commission payable of $103,736 at December 31, 2017; and payables of employees’ social insurance and disabled employment security fund of $128,927 at December 31, 2016, respectively.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2017
Related Party Transactions [Abstract]
Related Party Transactions	9. RELATED PARTY TRANSACTIONS Advance from a Shareholder At December 31, 2017 and 2016, the Company had advance from a major shareholder of $988,380 and $2,095,064, respectively. The advance was payable on demand, and bore no interest. Office lease from a Major Shareholder In May 2014, the Company entered a lease with its major shareholder for office use; the lease term was three years until May 2017 with an option to renew. The monthly rent was RMB 5,000 ($721), the Company was required to prepay each year’s annual rent at 15th of May of each year. The Company renewed the lease in May 2017 for another three years until May 28, 2020 with month rents of RMB 5,000 ($721), payable quarterly. The future annual minimum lease payment at December 31, 2017 is $8,652 for each of the years ending December 31, 2018, and 2019, and $4,326 for the year ending December 31, 2020.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2017
Income Tax Disclosure [Abstract]
Income Taxes	10. INCOME TAXES The Company was incorporated in the United States of America (“USA”) and has operations in one tax jurisdiction, i.e. the PRC. The Company generated substantially all of its net income from its operations in the PRC for the year ended December 31, 2017 and 2016, and has recorded income tax provision for the periods. Effective January 1, 2008, China adopted a uniform tax rate of 25% for all enterprises (including foreign-invested enterprises). However, the Company enjoys 10% preferential income tax rate for taxable income of RMB 0.5 million ($72,000) or less with a ‘Small Business’ status. The following table reconciles the PRC statutory rates to the Company’s effective tax rate for year ended December 31, 2017 and 2016: 2017 2016 Income tax at USA statutory rate (34%) (34.0 )% (34.0 )% Foreign rate differential 9 % 9 % Valuation allowance on NOL 25.0 % 25.0 % Tax (benefit) per financial statements - % - % For the years ended December 31, 2017 and 2016, the change in valuation allowance is mainly arise from the tax benefit on net operating loss carry forward for PRC and USA operation. Uncertain Tax Positions Interest associated with unrecognized tax benefits are classified as income tax, and penalties are classified in selling, general and administrative expenses in the statements of operations. For the years ended December 31, 2017 and 2016, the Company had no unrecognized tax benefits and related interest and penalties expenses. Currently, the Company is not subject to examination by major tax jurisdictions.

Loss Per Share

Loss Per Share	12 Months Ended
	Dec. 31, 2017
Earnings Per Share [Abstract]
Loss Per Share	11. LOSS PER SHARE The following table sets forth the computation of basic and diluted loss per share of common stock: Years Ended December 31, 2017 2016 Basic loss per share: Numerator: Net loss used in computing basic loss per share $ (4,255,214 ) $ (2,080,212 ) Denominator: Weighted average common shares outstanding 275,242,036 272,764,004 Basic loss per share $ (0.015 ) $ (0.008 ) Diluted loss per share: Numerator: Net loss used in computing diluted loss per share $ (4,255,214 ) $ (2,080,212 ) Denominator: Weighted average common shares outstanding 275,242,036 272,764,004 Diluted loss per share $ (0.015 ) $ (0.008 )

Shareholders_ Deficit

Shareholders’ Deficit	12 Months Ended
	Dec. 31, 2017
Equity [Abstract]
Shareholders’ Deficit	12. SHAREHOLDERS’ DEFICIT The Company is authorized to issue 20,000,000 shares of blank check preferred stock at $0.001 par value and 950,000,000 shares of common stock at $.00001 par value per share. At December 31, 2017, the Company had 317,988,089 shares issued and outstanding. Upon the Aixin reverse acquisition, the number of issued and outstanding shares was retroactively adjusted to reflect the recapitalization. As a result, at December 31, 2016, 272,764,004 shares were issued and outstanding after adjusted for the recapitalization.

Statutory Reserves

Statutory Reserves	12 Months Ended
	Dec. 31, 2017
Statutory Reserves
Statutory Reserves	13. STATUTORY RESERVES Pursuant to the PRC corporate law effective January 1, 2006, the Company is now only required to maintain one statutory reserve by appropriating from its after-tax profit before declaration or payment of dividends. The statutory reserve represents restricted retained earnings. Surplus reserve fund The Company is now required to transfer 10% of its net income, as determined under PRC accounting rules and regulations, to a statutory surplus reserve fund until such reserve balance reaches 50% of the Company’s registered capital. The surplus reserve fund is non-distributable other than during liquidation and can be used to fund previous years’ losses, if any, and may be utilized for business expansion or converted into share capital by issuing new shares to existing shareholders in proportion to their shareholding or by increasing the par value of the shares currently held by them, provided that the remaining reserve balance after such issue is not less than 25% of the registered capital. Common welfare fund Common welfare fund is a voluntary fund that the Company can elect to transfer 5% to 10% of its net income, as determined under PRC accounting rules and regulations, to this fund. The Company did not make any contribution to this fund during the years ended December 31, 2017 or 2016. This fund can only be utilized on capital items for the collective benefit of the Company’s employees, such as construction of dormitories, cafeteria facilities, and other staff welfare facilities. This fund is non-distributable other than upon liquidation.

Operating Risks

Operating Risks	12 Months Ended
	Dec. 31, 2017
Risks and Uncertainties [Abstract]
Operating Risks	14. OPERATING RISKS The Company’s operations in the PRC are subject to specific considerations and significant risks not typically associated with company in North America and Western Europe. These include risks associated with, among others, the political, economic and legal environments and foreign currency exchange. The Company’s results may be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversion and remittance abroad, and rates and methods of taxation, among other things. The Company’s sales, purchases and expenses are denominated in RMB and all of the Company’s assets and liabilities are also denominated in RMB. The RMB is not freely convertible into foreign currencies under the current law. In China, foreign exchange transactions are required by law to be transacted only by authorized financial institutions. Remittances in currencies other than RMB may require certain supporting documentation to effect the remittance.

Summary of Significant Accoun21

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2017
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying financial statements are prepared in conformity with U.S. Generally Accepted Accounting Principles (“US GAAP”). The functional currency of Aixin is Chinese Renminbi (‘‘RMB’’). The accompanying financial statements are translated from RMB and presented in U.S. dollars (“USD”).
Going Concern	Going Concern The Company incurred net losses of $4.3 million and $2.1 million for the years ended December 31, 2017 and 2016 respectively. The Company also had a shareholders’ deficit of $3.1 million as of December 31, 2017. These conditions raise a substantial doubt about the Company’s ability to continue as a going concern. The Company plans to increase its income by improving communications with suppliers to ensure sufficient and quality products supply, building a competitive and efficient sales force, providing attractive sales incentive program, increasing marketing and promotion activities, and minimize operating costs. The Company’s majority shareholder, Quanzhong Lin, plans to invest additional RMB 10 million into the Company by the end of July 2018 to help the Company’s working capital needs. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Use of Estimates	Use of Estimates In preparing financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Significant estimates, required by management, include the recoverability of long-lived assets, allowance for doubtful accounts, and the reserve for obsolete and slow-moving inventories. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Equivalents For financial statement purposes, the Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.
Accounts Receivable	Accounts Receivable The Company’s policy is to maintain an allowance for potential credit losses on accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. During the years ended December 31, 2017 and 2016, bad debt expense was $13,885 and $7,018, respectively. As of December 31, 2017 and December 31, 2016, the bad debt allowance was $24,524 and $9,475, respectively.
Inventory	Inventory Inventory mainly consists of health supplement products. Inventory is valued at the lower of average cost or market, cost being determined on a moving weighted average method at the end of the month. Management compares the cost of inventories with the net realizable value and an allowance is made for writing down their inventories to market value, if lower. The Company recorded inventory impairment of $14,468 and $0 at December 31, 2017 and 2016, respectively. In July 2015, the FASB issued Accounting Standards Update (“ASU”) 2015-11, “Inventory (Topic 330) - Simplifying the Measurement of Inventory,” which requires that inventory within the scope of the guidance be measured at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.
Property and Equipment	Property and Equipment Property and equipment are stated at cost, less accumulated depreciation, and impairment losses, if any. Major repairs and betterments that significantly extend original useful lives or improve productivity are capitalized and depreciated over the period benefited. Maintenance and repairs are expensed as incurred. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Building 20 years Office furniture 5 years Electronic Equipment 3 years Vehicles 5 years
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets Long-lived assets, which include property and equipment and intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable, but at least annually. Recoverability of long-lived assets to be held and used is measured by comparing of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by it. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds its fair value (“FV”). FV is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. Based on its review, the Company believes that, as of December 31, 2017 and December 31, 2016, there was no significant impairments of its long-lived assets.
Income Taxes	Income Taxes Income taxes are accounted for using an asset and liability method. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each period end based on enacted tax laws and statutory tax rates, applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. The Company follows Accounting Standards Codification (“ASC”) Topic 740, which prescribes a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740 also provides guidance on recognition of income tax assets and liabilities, classification of current and deferred income tax assets and liabilities, accounting for interest and penalties associated with tax positions, accounting for income taxes in interim periods, and income tax disclosures. Under ASC Topic 740, when tax returns are filed, it is likely that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. The benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50% likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination. Interest associated with unrecognized tax benefits is classified as interest expense and penalties are classified in selling, general and administrative expenses in the statement of income. At December 31, 2017 and 2016, the Company did not take any uncertain positions that would necessitate recording a tax related liability.
Revenue Recognition	Revenue Recognition The Company’s revenue recognition policies comply with FASB ASC Topic 605, “Revenue Recognition”. Sales are recognized when a formal arrangement exists; the price is fixed or determinable; title has passed to the buyer, which generally is at the time of delivery of the products or services; no other significant obligations of the Company exist and collectability is reasonably assured. Payments received before all of the relevant criteria for revenue recognition are recorded as unearned revenue. Sales revenue represents the invoiced value of goods, net of value-added taxes (“VAT”). All of the Company’s products sold in China are subject to the PRC VAT of 17% of the gross sales price. This VAT may be offset by VAT paid by the Company on raw materials and other materials purchased in China. The Company records VAT payable and VAT receivable net of payments in the financial statements. The VAT tax return is filed offsetting the payables against the receivables. Sales and purchases are recorded net of VAT collected and paid as the Company acts as an agent for the government. The Company’s sales policy allows for the return of unopened products for cash after deducting certain service and transaction fees. As alternatives for the product return option, the customers have options of asking an exchange of the products with same value. The amount for return of products was immaterial for the years ended December 31, 2017 and 2016.
Cost of Revenue	Cost of Revenue Cost of revenue (“COR”) consists primarily of cost of purchasing inventory. Write-down of inventory to lower of cost or market is also recorded in COR.
Concentration of Credit Risk	Concentration of Credit Risk The operations of the Company are in the PRC. Accordingly, the Company’s business, financial condition, and results of operations may be influenced by the political, economic, and legal environments in the PRC, and by the general state of the PRC economy. The Company has cash on hand and demand deposits in accounts maintained with state-owned banks within the PRC. Cash in state-owned banks is covered by insurance up to RMB 500,000 ($72,500) per bank. The Company has not experienced any losses in such accounts and believes they are not exposed to any risks on their cash in these bank accounts.
Statement of Cash Flows	Statement of Cash Flows In accordance with ASC Topic 230, “Statement of Cash Flows,”
Fair Value (“FV”) of Financial Instruments	Fair Value (“FV”) of Financial Instruments Certain of the Company’s financial instruments, including cash and equivalents, accrued liabilities and accounts payable, carrying amounts approximate their FV due to their short maturities. FASB ASC Topic 825, “Financial Instruments,” requires disclosure of the FV of financial instruments held by the Company. The carrying amounts reported in the balance sheets for current liabilities each qualify as financial instruments and are a reasonable estimate of their FV because of the short period of time between the origination of such instruments and their expected realization and the current market rate of interest.
Fair Value Measurements and Disclosures	Fair Value Measurements and Disclosures ASC Topic 820, “Fair Value Measurements and Disclosures,” defines FV, and establishes a three-level valuation hierarchy for disclosures of FV measurement that enhances disclosure requirements for FV measures. The three levels are defined as follow: ● Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets. ● Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. ● Level 3 inputs to the valuation methodology are unobservable and significant to the FV measurement. As of December 31, 2017 and 2016, the Company did not identify any assets and liabilities that are required to be presented on the balance sheet at FV.
Foreign Currency Translation and Comprehensive Income (Loss)	Foreign Currency Translation and Comprehensive Income (Loss) The functional currency of the Company is RMB. For financial reporting purposes, RMB is translated into USD as the reporting currency. Assets and liabilities are translated at the exchange rate in effect at the balance sheet dates. Revenues and expenses are translated at the average rate of exchange prevailing during the reporting period. Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders’ equity as “Accumulated other comprehensive income”. Gains and losses resulting from foreign currency transactions are included in income. There was no significant fluctuation in the exchange rate for the conversion of RMB to USD after the balance sheet date. The Company uses FASB ASC Topic 220, “Comprehensive Income”. Comprehensive income (loss) is comprised of net income (loss) and all changes to the statements of stockholders’ equity, except those due to investments by stockholders, changes in paid-in capital and distributions to stockholders. Comprehensive loss for 2017 and 2016 consisted of net loss and foreign currency translation adjustments.
Earnings Per Share	Earnings per Share Basic loss per share is computed on the basis of the weighted average number of common stock outstanding during the period. Diluted loss per share is computed on the basis of the weighted average number of common stock and common stock equivalents outstanding. Dilutive securities having an anti-dilutive effect on diluted loss per share are excluded from the calculation. Dilution is computed by applying the treasury stock method for options and warrants. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period. As of December 31, 2017 and 2016 and for the years then ended, the Company did not have any potentially dilutive instruments.
Stock-Based Compensation	Stock-Based Compensation The Company periodically grants stock options and warrants to employees and non-employees in non-capital raising transactions as compensation for services rendered. The Company accounts for stock option and stock warrant grants to employees based on the authoritative guidance provided by the FASB where the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and stock warrant grants to non-employees in accordance with the authoritative guidance of the FASB where the value of the stock compensation is determined based upon the measurement date at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option or warrant grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date. For the year ended December 31, 2017, the Company’s board of directors (“BOD”) authorized the issuance of 45,224,085 shares of common stock to three individuals for services rendered to the Company. The stock-based compensation was valued at $3,617,927 based on the Company’s stock price at the date of agreement and was vested immediately for services already rendered. On January 15, 2018, the Company’s BOD determined that it is not in the Company’s best interests to issue any shares to two of the three individuals because BOD believes the two individuals did not perform the services as expected
Segment Reporting	Segment Reporting ASC Topic 280, “Segment Reporting,” requires use of the “management approach” model for segment reporting. The management approach model is based on the way a company’s chief operating decision maker organizes segments within the Company for making operating decisions assessing performance and allocating resources. Reportable segments are based on products and services, geography, legal structure, management structure, or any other manner in which management disaggregates a company. Management determined that the Company’s operations constitute a single reportable segment in accordance with ASC 280. The Company operates exclusively in one business and industry segment: sale of health supplement products.
New Accounting Pronouncements	New Accounting Pronouncements In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers, which supersedes the revenue recognition requirements in Accounting Standards Codification 605 - Revenue Recognition and most industry-specific guidance throughout the Codification. The standard requires that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. In August 2015, the FASB approved a one-year deferral of the effective date of the new revenue recognition standard. Public business entities, certain not-for-profit entities, and certain employee benefit plans should apply the guidance in ASU 2014-09 to annual reporting periods beginning after December 15, 2017, including interim reporting periods within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 31, 2016, including interim reporting periods within that reporting period. In March 2016, the FASB issued ASU 2016-08, Revenue from Contracts with Customers (Topic 606), Principal versus Agent Considerations (Reporting Revenue versus Net). In April 2016, the FASB issued ASU 2016-10, Revenue from Contracts with Customers (Topic 606), Identifying Performance Obligations and Licensing. In May 2016, the FASB issued ASU 2016-11, Revenue from Contracts with Customers (Topic 606) and Derivatives and Hedging (Topic 815) - Rescission of SEC Guidance Because of ASU 2014-09 and 2014-16, and ASU 2016-12, Revenue from Contracts with Customers (Topic 606) - Narrow Scope Improvements and Practical Expedients. These ASUs clarify the implementation guidance on a few narrow areas and adds some practical expedients to the guidance Topic 606. The Company is evaluating the effect that these ASUs will have on its financial statements and related disclosures. In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326), which requires entities to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. This replaces the existing incurred loss model and is applicable to the measurement of credit losses on financial assets measured at amortized cost. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early application is permitted for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. The Company is currently evaluating the impact that the standard will have on its financial statements and related disclosures. In August 2016, the FASB issued ASU No. 2016-15, Classification of Certain Cash Receipts and Cash Payments. ASU 2016-15 clarifies the presentation and classification of certain cash receipts and cash payments in the statement of cash flows. This ASU is effective for public business entities for fiscal years, and interim periods within those years, beginning after December 15, 2017. Early adoption is permitted. The Company is currently assessing the potential impact of ASU 2016-15 on its financial statements and related disclosures. In November 2016, the FASB issued ASU No. 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash. The guidance requires that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. The standard is effective for fiscal years beginning after December 15, 2017, and interim period within those fiscal years. Early adoption is permitted, including adoption in an interim period. The standard should be applied using a retrospective transition method to each period presented. The Company does not anticipate the adoption of this ASU will have a significant impact on its financial statements.

Summary of Significant Accoun22

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2017
Accounting Policies [Abstract]
Schedule of Estimated Useful Lives of Property and Equipment	Depreciation of property and equipment is provided using the straight-line method for substantially all assets with 5% salvage value and estimated lives as follows: Building 20 years Office furniture 5 years Electronic Equipment 3 years Vehicles 5 years

Inventory (Tables)

Inventory (Tables)	12 Months Ended
	Dec. 31, 2017
Inventory Disclosure [Abstract]
Schedule of Inventory	Inventory consisted of the following at December 31, 2017 and 2016: 2017 2016 Finished goods – health supplements $ 63,930 $ 46,570 Less: Inventory impairment allowance (15,028 ) - Total $ 48,902 $ 46,570

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	12 Months Ended
	Dec. 31, 2017
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	Property and equipment consisted of the following at December 31, 2017 and 2016: 2017 2016 Office furniture $ 242,613 $ 226,385 Building 1,600,118 2,641,211 Vehicle 225,636 211,639 Electronic equipment 14,041 6,776 Total 2,082,408 3,086,012 Less: Accumulated depreciation (363,396 ) (269,078 ) Net $ 1,719,012 $ 2,816,934

Taxes Payable (Tables)

Taxes Payable (Tables)	12 Months Ended
	Dec. 31, 2017
Income Tax Disclosure [Abstract]
Schedule of Taxes Payable	Taxes payable consisted of the following at December 31, 2017 and 2016: 2017 2016 Income $ 37,629 $ 35,295 Value-added 1,149,055 1,075,161 City construction 50,218 47,137 Education 35,882 33,680 Other 17,766 1,777 Taxes payable $ 1,290,550 $ 1,193,050

Accrued Liabilities and Other26

Accrued Liabilities and Other Payables (Tables)	12 Months Ended
	Dec. 31, 2017
Payables and Accruals [Abstract]
Schedule of Accrued Liabilities and Other Payables	Accrued liabilities and other payables consisted of the following at December 31, 2017 and 2016: 2017 2016 Accrued liability – travel cost (see Note 4) $ 88,864 $ 114,726 Salary payable 97,393 53,714 Other payables 417,690 146,035 Total $ 603,947 $ 314,475

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2017
Income Tax Disclosure [Abstract]
Schedule of Effective Income Tax Rate	The following table reconciles the PRC statutory rates to the Company’s effective tax rate for year ended December 31, 2017 and 2016: 2017 2016 Income tax at USA statutory rate (34%) (34.0 )% (34.0 )% Foreign rate differential 9 % 9 % Valuation allowance on NOL 25.0 % 25.0 % Tax (benefit) per financial statements - % - %

Loss Per Share (Tables)

Loss Per Share (Tables)	12 Months Ended
	Dec. 31, 2017
Earnings Per Share [Abstract]
Schedule of Computation of Basic and Diluted Loss Per Share	The following table sets forth the computation of basic and diluted loss per share of common stock: Years Ended December 31, 2017 2016 Basic loss per share: Numerator: Net loss used in computing basic loss per share $ (4,255,214 ) $ (2,080,212 ) Denominator: Weighted average common shares outstanding 275,242,036 272,764,004 Basic loss per share $ (0.015 ) $ (0.008 ) Diluted loss per share: Numerator: Net loss used in computing diluted loss per share $ (4,255,214 ) $ (2,080,212 ) Denominator: Weighted average common shares outstanding 275,242,036 272,764,004 Diluted loss per share $ (0.015 ) $ (0.008 )

Organization and Description 29

Organization and Description of Business (Details Narrative) - USD ($)	Dec. 12, 2017	Feb. 02, 2017	Jan. 20, 2017	Nov. 09, 2009	Dec. 31, 2017
Entity incorporation, date of incorporation					Dec. 30, 1987
Entity incorporation, state country name					State of Colorado
Purchase price of common stock					$ 180,000
Quanzhong Lin [Member]
Aggregate number of common stock shares owned	256,874,014
Ownership percentage	80.80%
Number of common stock shares issued	227,352,604
Kanouff, LLC [Member]
Number of common stock shares purchased				200
Underwood Family Partners, Ltd [Member]
Number of common stock shares purchased				200
Algodon Wines & Luxury Development Group, Inc [Member]
Aggregate number of common stock shares owned				43,822,401
Ownership percentage				96.50%
China Concentric [Member]
Number of common stock sold, shares			43,822,401
Number of common stock sold			$ 260,000
Number of common stock shares purchased		29,521,410
Purchase price of common stock		$ 300,000
Ownership percentage		65.00%	96.50%
Repayment of non-interest bearing advances			$ 150,087
Stock Purchase Agreement [Member]
Number of common stock sold, shares				43,822,001
Number of common stock sold				$ 43,822
Sale of stock price per share				$ 0.001

Summary of Significant Accoun30

Summary of Significant Accounting Policies (Details Narrative)	12 Months Ended
	Dec. 31, 2017USD ($)shares	Dec. 31, 2016USD ($)	Dec. 31, 2017CNY (¥)	Dec. 31, 2015USD ($)
Net losses	$ 4,255,214	$ 2,080,212
Shareholders' deficit	3,070,114	2,015,365		$ 25,132
Bad debt expense	13,885	7,018
Bad debt allowance	24,524	9,475
Inventory impairment	$ 14,468
Property plant and equipment salvage value percentage	5.00%		5.00%
VAT of gross sales price percentage	17.00%
Cash in insurance covered by bank	$ 72,500
Number of common stock shares issued for services | shares	45,224,085
Stock-based compensation	$ 3,617,927
RMB [Member]
Investment | ¥			¥ 10,000,000
RMB [Member] | Maximum [Member]
Cash in insurance covered by bank | ¥			¥ 500,000

Summary of Significant Accoun31

Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Property and Equipment (Details)	12 Months Ended
	Dec. 31, 2017
Building [Member]
Estimated Useful Lives of Property and Equipment	P20Y
Office Furniture [Member]
Estimated Useful Lives of Property and Equipment	P5Y
Electronic Equipment [Member]
Estimated Useful Lives of Property and Equipment	P3Y
Vehicles [Member]
Estimated Useful Lives of Property and Equipment	P5Y

Deferred Commission (Details Na

Deferred Commission (Details Narrative) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Deferred Commission
Deferred commission	$ 422,594	$ 335,110

Deferred Travel Cost (Details N

Deferred Travel Cost (Details Narrative) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Deferred Travel Cost
Deferred travel cost	$ 277,261	$ 176,187

Inventory - Schedule of Invento

Inventory - Schedule of Inventory (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Inventory Disclosure [Abstract]
Finished goods - health supplements	$ 63,930	$ 46,570
Less: Inventory impairment allowance	(15,028)
Inventory	$ 48,902	$ 46,570

Property and Equipment, Net (De

Property and Equipment, Net (Details Narrative)	12 Months Ended
	Dec. 31, 2017USD ($)	Dec. 31, 2017CNY (¥)	Dec. 31, 2016USD ($)
Depreciation	$ 196,658		$ 211,114
Sale of property, plant and equipment	1,932,410
Repayment for advance from shareholder	$ 1,910,867
RMB [Member]
Sale of property, plant and equipment | ¥		¥ 13,060,000
Repayment for advance from shareholder | ¥		¥ 12,914,407

Property and Equipment, Net - S

Property and Equipment, Net - Schedule of Property and Equipment (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Property and equipment, gross	$ 2,082,408	$ 3,086,012
Less: Accumulated depreciation	(363,396)	(269,078)
Property and equipment, net	1,719,012	2,816,934
Office Furniture [Member]
Property and equipment, gross	242,613	226,385
Building [Member]
Property and equipment, gross	1,600,118	2,641,211
Vehicle [Member]
Property and equipment, gross	225,636	211,639
Electronic Equipment [Member]
Property and equipment, gross	$ 14,041	$ 6,776

Taxes Payables - Schedule of Ta

Taxes Payables - Schedule of Taxes Payable (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Taxes payable	$ 1,290,550	$ 1,193,050
Income [Member]
Taxes payable	37,629	35,295
Value-added [Member]
Taxes payable	1,149,055	1,075,161
City Construction [Member]
Taxes payable	50,218	47,137
Education [Member]
Taxes payable	35,882	33,680
Other [Member]
Taxes payable	$ 17,766	$ 1,777

Accrued Liabilities and Other38

Accrued Liabilities and Other Payables (Details Narrative) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Payables and Accruals [Abstract]
Payable to employees	$ 242,075	$ 128,927
Commission payable	$ 103,736

Accrued Liabilities and Other39

Accrued Liabilities and Other Payables - Schedule of Accrued Liabilities and Other Payables (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Payables and Accruals [Abstract]
Accrued liability - travel cost	$ 88,864	$ 114,726
Salary payable	97,393	53,714
Other payables	417,690	146,035
Total	$ 603,947	$ 314,475

Related Party Transactions (Det

Related Party Transactions (Details Narrative)	1 Months Ended
	May 30, 2017USD ($)	May 30, 2017CNY (¥)	May 30, 2014USD ($)	May 30, 2014CNY (¥)	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)
Advance from shareholder					$ 988,380	$ 2,095,064
Lease term			3 years	3 years
Monthly rent	$ 721		$ 721
Renew Lease	May 28, 2020	May 28, 2020
Future annual minimum lease payment					8,652
December 31, 2018 [Member]
Future annual minimum lease payment					8,652
December 31, 2019 [Member]
Future annual minimum lease payment					8,652
December 31, 2020 [Member]
Future annual minimum lease payment					$ 4,326
RMB [Member]
Monthly rent | ¥		¥ 5,000		¥ 5,000

Income Taxes (Details Narrative

Income Taxes (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Income tax rate
Preferential income tax rate	10.00%
Preferential income tax, amount	$ 72,000
RMB [Member]
Preferential income tax, amount	$ 500,000
China [Member]
Income tax rate	25.00%

Income Taxes - Schedule of Effe

Income Taxes - Schedule of Effective Income Tax Rate (Details)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Income Tax Disclosure [Abstract]
Income tax at USA statutory rate (34%)	(34.00%)	(34.00%)
Foreign rate differential	9.00%	9.00%
Valuation allowance on NOL	25.00%	25.00%
Tax (benefit) per financial statements

Income Taxes - Schedule of Ef43

Income Taxes - Schedule of Effective Income Tax Rate (Details) (Parenthetical)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Income Tax Disclosure [Abstract]
Statutory rate	34.00%	34.00%

Loss Per Share - Schedule of Co

Loss Per Share - Schedule of Computation of Basic and Diluted Loss Per Share (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Earnings Per Share [Abstract]
Net loss used in computing basic loss per share	$ (4,255,214)	$ (2,080,212)
Weighted average common shares outstanding, basic	275,242,036	272,764,004
Basic loss per share	$ (0.015)	$ (0.008)
Net loss used in computing diluted loss per share	$ (4,255,214)	$ (2,080,212)
Weighted average common shares outstanding, diluted	275,242,036	272,764,004
Diluted loss per share	$ (0.015)	$ (0.008)

Shareholders' Deficit (Details

Shareholders' Deficit (Details Narrative) - $ / shares	Dec. 31, 2017	Dec. 31, 2016
Equity [Abstract]
Preferred stock, shares authorized	20,000,000	20,000,000
Preferred stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	950,000,000	950,000,000
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, shares issued	317,988,089	272,764,004
Common stock, shares outstanding	317,988,089	272,764,004

Statutory Reserves (Details Nar

Statutory Reserves (Details Narrative)	12 Months Ended
	Dec. 31, 2017
Net income transfer percentage	10.00%
Capital reserve, percentage	50.00%
Minimum [Member]
Net income transfer percentage	5.00%
Capital reserve, percentage	25.00%
Maximum [Member]
Net income transfer percentage	10.00%